# Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

> **NCT02327546** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 10 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AKB-6548
- **DRUG:** Ferrous Sulfate

## Key facts

- **NCT ID:** NCT02327546
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327546, "Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02327546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*